Table 1.
Age (months) | WT | n | DL | n | DL+IVA | n |
---|---|---|---|---|---|---|
3 | 385±8 | 15 | 373±9 | 16 | 385±10 | 17 |
4.5 | 405±11 | 15 | 431±14* | 13 | 375±13§ | 16 |
6 | 381±15 | 15 | 465±10*,‡ | 10 | 422±11*,†,‡,§ | 14 |
Abbreviations: DL, dyslipidaemic mice; DL+IVA, dyslipidaemic mice treated with ivabradine; WT, wild-type mice.
DL+IVA mice were treated with ivabradine (IVA, 10 mg kg−1 day−1) from the age of 3 to 6 months. Data are mean±s.e.mean. *P<0.05 compared with 3 months; †P<0.05 compared with 4.5 months; ‡P<0.05 compared with the WT; §P<0.05 compared with DL. n refers to the number of animals used in each group.